Healio
›
Hematology/Oncology
›
Head/Neck Cancer
›
News
-
In the Journals
Perspective
-
-
HemOnc Today, September 25, 2012
-
Researchers identified a group of molecular markers that they believe can help clinicians determine whether low-grade oral premalignant lesions are at a...More
»
-
In the Journals
Perspective
-
-
Infectious Diseases in Children, October 2012
-
Many parents interviewed about their knowledge of HPV had a limited understanding of the disease, but most said they would have their son vaccinated if...More
»
-
In the Journals
-
-
HemOnc Today, September 25, 2012
-
The once-daily oral cancer drug vandetanib showed evidence of improved PFS in patients with locally advanced or metastatic differentiated thyroid cancer,...More
»
-
Pharmacology Consult
-
-
HemOnc Today, August 25, 2012
Lisa K. Lohr, PharmD, BCPS, BCOP
-
Lisa K. Lohr
The use of oral cancer chemotherapy agents has risen dramatically during the past several years.
This trend appears to be continuing, as the...More
»
-
In the Journals
-
-
HemOnc Today, September 25, 2012
-
Long-term use of blood pressure medications that increase a person’s sensitivity to sunlight may raise the risk for lip cancer among non-Hispanic...More
»
-
Meeting News Coverage
Perspective
-
-
HemOnc Today, September 10, 2012
-
Patients with advanced squamous cell carcinoma of the head and neck who were treated at high-volume hospitals and NCI-designated cancer centers...More
»
-
Meeting News Coverage
Perspective
-
-
HemOnc Today, July 25, 2012
-
Results of the phase 3 PARADIGM trial showed no significant differences in OS among patients with locally advanced head and neck cancers who were treated...More
»
-
Meeting News Coverage
-
-
HemOnc Today, July 25, 2012
-
Gregory T. Armstrong
Middle-aged childhood cancer survivors were at increased risk for a number of chronic health conditions, ranging from myocardial...More
»
-
Perspective
-
-
HemOnc Today, July 25, 2012
-
Stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria did not result in increased survival, according to results of a...More
»
-
In the Journals
-
-
HemOnc Today, August 25, 2012
-
Lower doses of radioactive iodine removed leftover cancer cells as effectively as higher doses in patients with thyroid cancer, two studies found.
The...More
»